Recently, Shanghai Medicilon was awarded the title of “Excellent Expert Workstation” by the Shanghai Academician and Expert Workstation Guidance Office and the title of “2020 Pudong New Area Excellent Academician and Expert Workstation” by the Pudong Science and Technology Association. Medicilon was awarded the title of “Excellent Expert Workstation” by the Shanghai Academician Expert WorkstationRead more
Blog
By medicilon | Medicilon Events | Comments are Closed | 13 January, 2021 |
By medicilon | Medicilon Events | Comments are Closed | 4 January, 2021 |
You may say that the Coronavirus Pandemic will define 2020. You may say that 2020 has given us more than our fair share of challenges and obstacles. But that doesn’t mean great achievements in 2020 didn’t occur! Medicilon embodies its motto of being “Innovation-driven, quality-focused” and keeps on maintaining and improving its technology and qualityRead more
By medicilon | Medicilon Events | Comments are Closed | 25 December, 2020 |
Dec.20, 2020, Hebei—The 13th China Pharmaceutical Strategy Conference 2020 was held successfully. The conference presented the list of “the 2020 TOP10 Innovation CRO in China”. The list included the 10 CRO that made tremendous innovation and achievements and Medicilon was honored to be one of the 10. 13th China Pharmaceutical Strategy Conference In the pastRead more
By medicilon | Medicilon Events | Comments are Closed | 25 December, 2020 |
Medicilon has constructed the GMP Drug Products Pilot Plant to meet the rising needs for innovative medicine R&D, production, packaging, inspections and stability tests. We are aiming for qualified CDMO services for clients with requirements for the development of innovative medicine. CDMO Service Platform Our GMP Drug Products Pilot Plant can meet the production andRead more
By medicilon | Medicilon Events | Comments are Closed | 4 December, 2020 |
Shanghai, China, Dec. 2nd, 2020 — CGeneTech (Suzhou, China) Co., Ltd and Medicilon Inc. successfully held the conference titled “PROTAC project contract signing & kick-off meeting”. The conference adopted virtual digital mode due to the influence of COVID-19. The attendees are listed below: CGeneTECH (Suzhou, China) Co, Ltd Dr. Yu Qiang, CEO of CGeneTech Dr.Read more
By medicilon | Medicilon Events | Comments are Closed | 1 December, 2020 |
In recent years, tumor immunotherapy has become the core of cancer treatment research. With innovation as the driving force, Medicilon has vigorously developed a tumor immunity (Immuno-oncology) drug efficacy evaluation research platform. At present, CAR-T, TCR-T, CAR-NK, Oncolytic Virus, antibodies (monoclonal antibodies, double antibodies, polyclonal antibodies, etc.), siRNA, AAV and other immunotherapy models and methodsRead more
By medicilon | Medicilon Events | Comments are Closed | 24 November, 2020 |
#medicilon #thanksgiving #drugdiscoveryRead more
By medicilon | Medicilon Events | Comments are Closed | 16 November, 2020 |
#Medicilon will exhibit the ACT 2020 Annual Meeting Nov 12-19. Please visit our virtual booth for our #toxicology services. We look forward to see you. Please visit the ACT website for more details. https://www.actox.org/am/am2020/index.asp #Medicilon #Toxicology #DrugDiscovery #ACTOX2020 # ACToxicologyRead more
By medicilon | Medicilon Events | Comments are Closed | 11 November, 2020 |
Medicilon will exhibit the SAPA-CT Annual Conference on Nov 14, 2020. Please visit https://us02web.zoom.us/webinar/register/WN_EVYTAJv6TZGe1Yg0DgguIw to register the free admission. Our CEO, Dr. Chunlin Chen, is invited to give a presentation on the topic of “Strategy for IND Submission to both US FDA and Chinese NMPA” We look forward to see you. #Medicilon #IND #DrugDiscovery #SAPARead more